VDVladimir Sergeevich Davydenko

Vladimir Sergeevich Davydenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vladimir Sergeevich Davydenko has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular modeling of complexes between mutant forms of chemokines CXCL2 and CXCL3 and the HIV-1 co-receptor CCR5: in silico identification of variants with enhanced stability and binding energy

    by V. S. Davydenko, A. N. Shchemelev, Yu. V. Ostankova, A. A. Totolian

    Introduction. Attachment of HIV-1 proteins to CCR5 is the initiating step of viral entry into the cell. Blockade of this pathway can be achieved through natural ligands of the organism. Previously, we performed a bioinformatics screening that identified the chemokines CXCL2 and CXCL3 as potential CCR5 ligands. The aim of this study was to conduct an in silico assessment of the impact of naturally occurring missense mutations in CXCL2 and CXCL3 on the stability and binding energy of their complexes with CCR5, in order to identify variants with enhanced affinity. Materials and methods. Missense mutations located within predicted CCR5 contact sites were selected from the UniProt database. Three-dimensional structures of wild-type complexes were built using AlphaFold. Mutant variants of CXCL2 (38 substitutions) and CXCL3 (45 substitutions) were modeled using FoldX. Changes in the free energy of complex stability (ΔStability) and interaction energy (ΔConnection) were calculated, along with functional significance predictions using PolyPhen-2. Selection criteria were ΔStability ≤ –1.0, ΔConnection ≤ –1.0, and a benign (neutral) status. For statistical classification of mutations by their type of effect, cluster analysis was performed using the k-means method in IBM SPSS Statistics 27. Results. The interaction profiles of the wild-type ligands with CCR5 differ: the CXCL2–CCR5 complex is characterized by a lower stability energy. Simultaneous improvement in both parameters was recorded for 12 CXCL2 variants and 7 CXCL3 variants. Candidates with improved parameters and a benign status were identified: for CXCL2 — S29C, R30P, Q44R; for CXCL3 — V38L, A70P. Cluster analysis identified a group of mutations with the most pronounced improvement in binding (L41P, L41M, R42C, H68R for CXCL2; R42G, R42H, R42L for CXCL3), all of which are predicted to be likely disruptive. Position 42 was found to be a significant interaction region: mutations at this site showed the most pronounced improvement in parameters (ΔConnection down to –6.94 kcal/mol). The L49P mutation in both ligands exhibited a strongly destabilizing effect. Conclusions. This is the first systematic computational analysis of the impact of missense mutations in CXCL2 and CXCL3 on their interaction with CCR5. The identified mutant forms that combine improved affinity with retained predicted functional activity, as well as mutations from the improving cluster, warrant further experimental validation of their ability to block HIV-1 attachment.

  • Open Access

    High Burden of Occult Hepatitis B Infection in HIV-Infected Patients in Southern Vietnam: Insights from Serological and Molecular Analysis

    by Huynh Hoang Khanh Thu, Yulia V. Ostankova, Alexander N. Shchemelev, Elena N. Serikova, Vladimir S. Davydenko, Nadezhda A. Pechnikova, Tran Ton, Truong Thi Xuan Lien, Edward S. Ramsay, Areg A. Totolian

    Hepatitis B virus (HBV) infection remains a major concern among people living with HIV (PLWH), particularly in high-endemic settings such as Vietnam. The study evaluated the serological and molecular characteristics of HBV among PLWH receiving antiretroviral therapy (ART) in southern Vietnam. A cross-sectional study was conducted among 316 HIV-infected patients receiving ART. Serological markers (HBsAg, anti-HBs IgG, and anti-HBc IgG) and HBV DNA were assessed using highly sensitive assays, and the Pre-S1/Pre-S2/S regions were sequenced for genotype and mutation analysis. Associations were evaluated using appropriate statistical methods. HBV DNA was detected in 32.6% of the patients, whereas HBsAg was present in only 16.1%. The most common serological profile was susceptibility (36.4%), followed by occult HBV infection (OBI) (17.4%), including 6.6% with completely seronegative OBI, and chronic HBV (CHB) (15.8%). Males and older individuals showed a significantly higher risk of CHB (adjusted odds ratio [aOR] = 2.58 and aOR = 1.87, respectively). Genotype B predominated (78.4%) overall, but genotype C was significantly more frequent in OBI than in CHB patients (31.5% vs. 8.3%, p = 0.008). Moreover, the burden of surface S gene escape mutations was significantly higher in the OBI group (p = 0.023). The LASSO model showed a moderate discriminatory ability for predicting OBI status (Area Under the Receiver Operating Characteristic [ROC] Curve [AUC] = 0.76). Lamivudine-associated resistance (rtM204I/V) was the most common RT mutation detected in the overlapping RT/S region. HIV-infected individuals in southern Vietnam face a burden of both CHB and OBI, including a high proportion of seronegative OBI. The presence of seronegative OBI further supports the risk of underdiagnosis when relying only on standard serological markers, and reflects the need for integrated strategies combining highly sensitive serological assays with molecular diagnostics to improve HBV detection among high-risk populations.

  • Open Access

    Identifying Conserved Regions in HIV-1 Proteins by Entropy Analysis of Sequence Variability

    by Alexandr N. Shchemelev, Elena N. Serikova, Yulia V. Ostankova, Vladimir S. Davydenko, Edward S. Ramsay, Areg A. Totolian

    The extraordinary genetic diversity of human immunodeficiency virus type 1 (HIV-1), driven by high mutation and recombination rates, poses significant challenges for diagnostics, therapy, and vaccine development. While variable regions enable immune escape, hyperconserved regions are critical for viral function and represent promising targets for novel therapeutic interventions. This study aimed to develop and validate a bioinformatic algorithm for quantitative assessment of sequence conservation and automated identification of functionally significant conserved regions across all major HIV-1 proteins. A total of 1119 full-length HIV-1 genome sequences representing major subtypes (A1, A2, A6, B, C, D, F1, F2, G, H, J, K) were analyzed. Normalized Shannon entropy (S-index) was calculated for each alignment column. Statistical thresholds for conserved regions were established using 95% confidence intervals derived from bootstrap resampling. Two complementary algorithms, clustering and local maxima detection, were applied to identify conserved regions, which were subsequently mapped to known functional domains based on literature data. Protein conservation varied markedly, with Sm values ranging from 0.784 (Vpu) to 0.920 (Pol). Gag, Pol, and Vpr demonstrated the highest overall conservation, while Env, Rev, Tat, and Vpu exhibited pronounced variability interspersed with conserved domains. In total, 25 conserved regions in Gag, 49 in Pol, 28 in Env, and 6–4 regions in accessory proteins (Vif, Vpr, Rev, Tat, Nef, Vpu) were identified. These regions corresponded to critical functional elements including enzyme catalytic centers, zinc fingers, receptor-binding sites, protein interaction interfaces, and membrane-anchoring domains. The developed computational framework enables statistically grounded identification of evolutionarily constrained regions across analyzed HIV-1 subtypes. The identified conserved regions represent candidate sites for further investigation and may inform downstream studies focused on antiviral target prioritization, immunogen design, and diagnostic assay development. However, their translational applicability requires additional analytical, structural, and experimental validation.

  • Open Access

    A comparative analysis of HB markers and profiles between HIV-infected patients and healthy adults in Southern Vietnam

    by Hoang Khanh Thu Huynh, Yulia V. Ostankova, Alexandr N. Schemelev, Elena N. Serikova, Vladimir S. Davydenko, Ton Tran, Thi Xuan Lien Truong, Areg A. Totolian, Чан Тон, Чыонг Тхи Суан Льен

    Background. Southern Vietnam is hyperendemic for Hepatitis B virus (HBV) infection, yet comparative data on the full spectrum of HB serological and molecular profiles — including susceptibility and occult infection — between HIV-infected and healthy adults in this setting remain limited. The aim of this study was to comprehensively evaluate and compare the serological and molecular markers and profiles of Hepatitis B virus infection between HIV-infected patients and apparently healthy adults in Southern Vietnam. Materials and methods. A comparative cross-sectional study was conducted on 713 participants (316 HIV-infected and 397 healthy adults). Blood plasma samples were screened for HBsAg, anti-HBs IgG, and anti-HBc IgG markers. HBV DNA testing was performed using a high-sensitivity in-house PCR. Multivariable logistic regression and interaction analyses were employed for comparative analysis. Results. HBsAg prevalence was comparably high in both the healthy (17.6%) and HIV-infected (16.1%) cohorts, reflecting early-life exposure. However, the HIV cohort exhibited a significantly higher rate of seronegativity for all markers (43.0% vs 16.1%; p 0.001). The burden of OBI was two-fold higher in the HIV group (17.1%) compared to healthy controls (9.3%; aOR = 2.00). Notably, 6.65% of seronegative HIV patients (“triple-negative”) tested positive for HBV DNA, a prevalence 13-fold higher than in controls (0.50%). Age-trend analysis revealed that while healthy adults accumulated immunity with age, HIV-infected individuals exhibited “immune erasure” and seroreversion, leading to the loss of protective antibodies and increased risk of occult infection in older age. Conclusion. Our study documents important differences in HBV serological and molecular profiles between HIV-infected patients and healthy adults in a hyper-endemic setting. Our cross-sectional data are consistent with HIV-associated perturbation of humoral immunity, manifested by higher rates of seronegativity. The detection of triple-negative occult HBV infection highlights a limitation of serology-only screening. In endemic settings, clinicians and public health programs should therefore consider risk-stratified approaches that incorporate molecular testing, particularly for high-risk subgroups where universal screening is not feasible.

  • Open Access

    Identification and multiparametric ranking of candidate genes involved in hepatitis C virus entry and host immune response using bioinformatics methods

    by Ekaterina V. Anufrieva, Yulia V. Ostankova, Vladimir S. Davydenko, Alexander N. Shchemelev, Areg A. Totolian, Щемелев Александр Николаевич

    Introduction. Hepatitis C virus (HCV) remains a significant public health concern. The application of existing antiviral agents is restricted by their high cost and the development of viral resistance, while vaccine development is impeded by the considerable genetic variability of HCV. The outcome of infection is largely determined by the host's genetic factors, which influence both the viral entry into the cell and the effectiveness of antiviral immunity. Identification of genetic determinants involved in these processes is essential for understanding pathogenesis and discovering novel therapeutic targets. Objective. A comprehensive assessment of the potential involvement of candidate genes and their products in the pathogenesis of HCV infection at the stages of viral entry into the cell and the formation of the host immune response, based on an integrative analysis of gene expression, subcellular localization of their products, and participation in molecular pathways and biological processes. Materials and methods. In this study, a comparative analysis of 35 most promising candidate genes was performed against five background genes (CD81, CLDN1, LDLR, OCLN, SCARB1) encoding key HCV entry receptors. To analyze biological mechanisms associated with priority genes, the FUMA GWAS platform was used in the functional mapping mode GENE2FUNC (https://fuma.ctglab.nl/gene2func). Evaluation of candidate genes included analysis of their expression profiles, subcellular localization of protein products, as well as involvement in molecular pathways and biological processes. A ranking scoring system was developed, based on point-based ranking, which allowed determining the significance of each candidate gene in the context of its potential involvement in HCV pathogenesis. The system includes sequential assessment by several independent criteria, the results of which are summed into a single score. The degree of association between candidate genes and background genes was assessed using the phi-correlation coefficient (φ) across categories of subcellular localization, molecular pathways, and biological processes. Results. Application of the developed scoring system identified 25 significant candidate genes. The highest scores were obtained for genes involved in intercellular junction organization (CLDN3, CLDN5, CLDN12, ESAM, F11R, TJP1, TJP2) and lipid metabolism regulation (APOE, LDLRAP1). Enrichment of several candidate genes in immunological processes was revealed. A stable association of C3 and CD19 genes with immune process regulation was established, which is of particular interest in light of HCV's ability to infect mononuclear cells. The APOE, ITGB1, F11R genes demonstrated involvement in inflammatory and defense responses, while IFITM1 was associated with response to cytokine stimulation. Conclusion. A group of candidate genes potentially influencing HCV infection pathogenesis both at the viral entry stage and through immune modulation was identified. The obtained data expand understanding of virus-host interactions and justify the need for experimental validation of the identified genes as potential biomarkers and therapeutic targets.

  • Open Access

    Selective enhancement of PNOC protein binding to HIV-1 co-receptors CCR5 and CXCR4 by missense mutations: a computational analysis and prediction

    by V. S. Davydenko, A. N. Shchemelev, Yu. V. Ostankova, A. A. Totolian

    The aim of this study was a systematic in silico evaluation of the effect of natural missense mutations in PNOC on the stability and binding energy of its complexes with CCR5 and CXCR4 to identify variants with enhanced affinity, potentially suitable for inhibiting viral entry. Materials and methods . Three-dimensional structures of wild-type PNOC protein complexes with CCR5 and CXCR4 were built using molecular modeling methods with the AlphaFold algorithm. Based on these, mutant PNOC variants localized at the receptor contact sites were modeled using the FoldX program. To quantitatively assess the mutation effects, we calculated the change in the complex stability free energy (∆Stability) and the protein-protein interaction energy (∆Connection), analyzed the change in the number of atomic contacts (∆Contacts), and predicted the functional impact of the substitutions using the PolyPhen-2 algorithm. Results and discussion . The wild-type PNOC was shown to have a higher predicted affinity for CXCR4 compared to CCR5. For the PNOC-CCR5 complex, one candidate (E50K) was identified that fully met the strict selection criteria (decrease in both ∆Stability and ∆Connection, preserved number of contacts, «benign» status). For the PNOC-CXCR4 complex, a broader spectrum of significant mutations was revealed, among which four (F14L, S20N, R23K, V43M) met all the criteria. Mutations with selective action are of particular interest: E50K (improves binding to CCR5 but impairs it for CXCR4) and F14L (the only mutation that improves binding parameters for both receptors). Conclusion . For the first time, a systematic computational analysis of the impact of PNOC missense mutations on its interaction with HIV-1 co-receptors has been conducted. Specific amino acid substitutions (E50K for CCR5; F14L, Q22P, and others for CXCR4) that statistically significantly improve the binding energy and complex stability have been identified. These mutant PNOC forms represent promising candidates for further experimental validation of their ability to inhibit viral binding to the target cell and can be considered as a basis for developing new strategies for antiviral therapy.


  • Open Access

    Unveiling the Hidden Reservoir: High Prevalence of Occult Hepatitis B and Associated Surface Gene Mutations in a Healthy Vietnamese Adult Cohort

    by Huynh Hoang Khanh Thu, Yulia V. Ostankova, Alexander N. Shchemelev, Elena N. Serikova, Vladimir S. Davydenko, Tran Ton, Truong Thi Xuan Lien, Edward S. Ramsay, Areg A. Totolian

    Vietnam faces a hyperendemic burden of hepatitis B virus (HBV) infection, but the prevalence of occult HBV infection (OBI) and its underlying molecular mechanisms in healthy populations remain poorly understood. This study aimed to characterize the serological and molecular HBV profile of a healthy Vietnamese adult cohort in Southern Vietnam. We assessed the prevalence of occult HBV infection (OBI) and HBsAg-positivity (serving as a proxy for probable chronic infection). In this cross-sectional study, 397 healthy adults from Southern Vietnam underwent serological screening for HBsAg, anti-HBs, and anti-HBc. All participants were screened for HBV DNA using a high-sensitivity PCR assay (LOD ≥ 5 IU/mL). For all viremic cases, the full Pre-S/S region was sequenced to determine genotype and characterize escape mutations. We uncovered a high prevalence of both HBsAg-positivity (17.6%) and OBI (9.3% HBsAg-negative, HBV DNA-positive). Serological analysis revealed a massive, age-dependent reservoir of past exposure (63.7% anti-HBc) characterized by a high and increasing prevalence of the anti-HBc only profile (31.5%), a key serological marker for OBI. This trend contrasted sharply with a steep age-related decline in protective anti-HBs. The viral landscape was dominated by genotypes B (73.8%) and C (26.2%), with sub-genotypes B4 and C1 being the most prevalent. Critically, individuals with OBI carried a significantly higher burden of S gene escape mutations compared to those with HBsAg-positivity (p < 0.001). Canonical escape variants, including sG145R (21.6%), sK141R/T/E/Q (24.3%), and sT116N/A/I/S (18.9%), were exclusively or highly enriched in the OBI group. A LASSO-logistic model based on this mutational profile successfully predicted occult infection with high accuracy (AUC = 0.83). A substantial hidden reservoir of occult HBV infection exists within the healthy adult population of Vietnam, driven by a high burden of S gene escape mutations. These findings highlight the significant limitations of conventional HBsAg-only screening. They also underscore the need for comprehensive molecular surveillance to address the true scope of HBV viremia, hopefully enabling a reduction in hidden transmission of clinically significant viral variants.


  • Open Access

    Effects of CCL2 chemokine missense mutations on CCR5 receptor affinity: a computational study in the context of HIV infection regulator discovery

    by V. S. Davydenko, Alexandr N. Schemelev, Y. V. Ostankova, E. V. Anufrieva, A. A. Totolian

    Introduction. HIV entry into host cells requires CD4 receptors and CCR5 co-receptors. Natural CCR5 ligands can inhibit HIV through steric blocking and receptor internalization. Although CCL2 is primarily a CCR2 ligand, emerging evidence suggests possible CCR5 interaction, challenging conventional views of chemokine specificity. Natural CCL2 missense mutations provide valuable insights into receptor interaction mechanisms and their potential role in HIV infection modulation, offering new perspectives on viral entry inhibition strategies. Materials and methods. The wild-type complex was modeled using AlphaFold Server with rigorous validation. From UniProt database, we selected 41 CCL2 mutations within predicted CCR5 binding sites based on structural analysis. For each variant, we generated mutant protein structures and complex models using FoldX algorithm in YASARA environment. We calculated binding energies, complex stability, and interaction energy parameters, while conducting detailed analysis of atomic contacts and hydrogen bonding patterns. Functional impact of mutations was assessed using PolyPhen-2 algorithm. Results. Molecular modeling identified 35 CCL2 residues forming the comprehensive CCR5 interface. Five specific mutations (P78H, S57C, I28V, N29A, K79A) significantly enhanced CCR5 binding affinity, reducing interaction energy compared to wild type. P78H and S57C variants showed the strongest effects and were consistently predicted as “probably damaging”. K79A demonstrated substantially improved binding while maintaining reasonable interfacial contacts. Detailed structural analysis revealed these mutations optimize the binding interface through strategic reorganization of molecular interactions and improved complementarity. Discussion. Our findings demonstrate that specific natural CCL2 mutations can substantially enhance CCR5 binding affinity, revealing unexpected plasticity in chemokine-receptor recognition systems. The most impactful mutations suggest evolutionary mechanisms for modulating HIV entry pathways through natural genetic variation. These results provide structural insights into how sequence variations might influence viral pathogenesis through altered receptor specificity and binding kinetics. Conclusion. This computational study identifies key CCL2 mutations that significantly enhance CCR5 binding, expanding our understanding of chemokine system flexibility and evolutionary adaptation. The results support further experimental investigation of natural CCL2 variants as potential modulators of HIV infection and contribute to fundamental knowledge of virus-host interactions at molecular level.

  • Analysis of some IFNAR1 gene polymorphisms in HIV-infected patients

    by Yu. V. Ostankova, V. S. Davydenko, A. N. Schemelev, A. A. Totolian

    The aim of this study was to examine the genotypic and allelic distribution of certain polymorphic variants of the IFNAR1 gene in HIV-positive patients and evaluate their association with HIV infection. Materials and methods . The study material consisted of whole blood samples obtained from HIV-infected individuals with virological failure of antiretroviral therapy (n=378) and apparently healthy individuals (n=319). We performed sequencing of all exons of the IFNAR1 gene with partial coverage of flanking intronic sequences, including analysis of the promoter region and a substantial intronic segment in the pre-promoter region, followed by analysis of the obtained nucleotide sequences. Results and discussion . We demonstrated statistically significant associations with HIV infection for three polymorphic variants of the IFNAR1 gene: rs2843710 (–654 C/G), rs2257167 (exon 4, 18339G>C: Val168Leu), and rs2856973 (intron 10, 28767 A>T). The genotype distribution of all studied polymorphic variants in the analyzed groups conformed to HardyWeinberg equilibrium. Significant differences in genotype distribution were shown between HIV-infected individuals and the control group: rs2843710 — х 2 =9.624 at p=0.0081; rs2257167 — х 2 =8.623 at p=0.0134; rs2856973 — х 2 =10.447 at p=0.0054. The homozygous C/C genotype and minor C allele of rs2257167 locus were associated with predisposition to HIV infection, while the G/G (rs2843710) and T/T (rs2856973) genotypes along with their corresponding G and T alleles demonstrated a pronounced protective effect. Conclusion . This study reveals an association between IFNAR1 gene polymorphisms and a predisposition to HIV infection, demonstrating their significant, albeit non-exclusive, role in the disease development.

  • Open Access

    Modeling Human Protein Physical Interactions Involved in HIV Attachment In Silico

    by Vladimir S. Davydenko, Alexander N. Shchemelev, Yulia V. Ostankova, Ekaterina V. Anufrieva, Areg A. Totolian

    The human immunodeficiency virus (HIV) remains a major global health challenge. A promising therapeutic strategy involves identifying human proteins capable of physically blocking viral entry by interacting with key components of the HIV attachment system. To address this challenge systematically, we developed a computational pipeline for prioritizing protein–protein interaction and applied it to identify host proteins interacting with the viral glycoprotein gp120 and cellular receptors (CD4, CCR5, CXCR4, CCR2). Our approach combined large-scale interaction modeling using AlphaFold 3 with a comprehensive comparative analysis framework. We screened a panel of 55 candidate human proteins selected through integrated bioinformatics analysis. The pipeline incorporated model confidence assessment, quantitative contact analysis, and normalization against reference interactions to generate a robust ranking of candidates. Key findings reveal several important patterns. Chemokine CCL27 uniquely demonstrated high binding potential to both CCR5 co-receptor and viral gp120, suggesting its potential for dual-blockade capability. Analysis of natural ligand interactions with chemokine receptors showed marked disparity: CC-chemokine family members exhibited significantly greater binding capacity for CCR5 and CCR2 receptors compared to CXC-family ligand interactions with CXCR4. This binding imbalance may potentially drive selective viral pressure and influence tropism evolution during disease progression. We also identified potential interactions between HIV entry components and neuropeptides including PNOC and NPY, as well as various membrane receptors beyond classical coreceptors. Furthermore, cluster analysis revealed clear separation between receptor-type and ligand-type interactors, supporting the biological plausibility of our predictions. While acknowledging limitations related to model refinement, this study provides a systematically ranked set of candidate targets for HIV therapeutic development. Beyond identifying specific HIV interaction candidates, this study establishes a generalizable computational pipeline for the prioritization of protein–protein interaction in pathogen-host systems, effectively bridging large-scale modeling.